Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RITUXIMAB-ABBS Cause Maternal exposure timing unspecified? 19 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Maternal exposure timing unspecified have been filed in association with RITUXIMAB-ABBS. This represents 0.4% of all adverse event reports for RITUXIMAB-ABBS.

19
Reports of Maternal exposure timing unspecified with RITUXIMAB-ABBS
0.4%
of all RITUXIMAB-ABBS reports
19
Deaths
19
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From RITUXIMAB-ABBS?

Of the 19 reports, 19 (100.0%) resulted in death, 19 (100.0%) required hospitalization, and 19 (100.0%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-ABBS. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does RITUXIMAB-ABBS Cause?

Off label use (2,167) Intentional product use issue (273) Dyspnoea (208) Pain (205) Rheumatoid arthritis (202) Intentional dose omission (196) Fatigue (195) Drug ineffective (186) Hypertension (183) Infusion related reaction (183)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which RITUXIMAB-ABBS Alternatives Have Lower Maternal exposure timing unspecified Risk?

RITUXIMAB-ABBS vs RITUXIMAB-ARRX RITUXIMAB-ABBS vs RITUXIMAB-PVVR RITUXIMAB-ABBS vs RIVAROXABAN RITUXIMAB-ABBS vs RIVASTIGMINE RITUXIMAB-ABBS vs RIVOTRIL

Related Pages

RITUXIMAB-ABBS Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified RITUXIMAB-ABBS Demographics